RxNorm Semantic Concepts Index - 337
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "337".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 337000 | trimipramine 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337002 | zinc oxide 180 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337004 | carbetapentane 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337006 | amylase 60000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337007 | potassium chloride 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337008 | guaiacol 0.0026 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337012 | magnesium hydroxide 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337013 | sulfiSOXAZOLE 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337013 | sulfiSOXAZOLE 600 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 337014 | lipase 2000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337015 | amylase 75000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337016 | aspirin 259 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337017 | salicylamide 97.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337018 | castor oil 650 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337019 | benzocaine 0.325 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337021 | calcium carbonate 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337022 | peptone,dried 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337023 | phenolphthalein 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337024 | folic acid 1.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337027 | amylase 30000 UNT / lipase 8000 UNT / protease 30000 UNT Oral Tablet [Panokase] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 337027 | amylase 30000 UNT / lipase 8000 UNT / protease 30000 UNT Oral Tablet [Panokase] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337027 | amylase 30000 UNT / lipase 8000 UNT / protease 30000 UNT Oral Tablet [Panokase] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337028 | phenolphthalein 60 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 337029 | phenolphthalein 97.2 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 337032 | sodium phosphate 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 337039 | zinc gluconate 10 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 337045 | Aranesp | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 337068 | Methyl 5-aminolevulinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 337068 | Methyl 5-aminolevulinate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 337068 | Methyl 5-aminolevulinate | Designated preferred name (PT) | YES | |
| RxCUI: 337068 | Methyl 5-aminolevulinate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 337068 | Methyl 5-aminolevulinate | Full form of descriptor (FN) | YES | |
| RxCUI: 33712 | pimethixene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33717 | pinacidil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33724 | pinaverium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33725 | Pinazepam | Designated preferred name (PT) | NO | |
| RxCUI: 33725 | Pinazepam | Full form of descriptor (FN) | NO | |
| RxCUI: 33725 | Pinazepam | Designated preferred name (PT) | NO | |
| RxCUI: 33725 | Pinazepam | Full form of descriptor (FN) | NO | |
| RxCUI: 337250 | Substance with endothelin receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 337250 | Substance with endothelin receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 337250 | Substance with endothelin receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 337250 | Substance with endothelin receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337250 | Substance with endothelin receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 337280 | zinc gluconate 10.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337281 | hyaluronidase 1500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337283 | aurothioglucose 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337284 | calcium glubionate 5230 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337285 | calcium glubionate 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337286 | calcium glubionate 218 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337287 | calcium gluceptate 10.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337288 | calcium gluconate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337289 | calcium gluconate 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337290 | calcium gluconate 650 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337291 | calcium gluconate 0.025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337292 | calcium gluconate 5.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337293 | calcium gluconate 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337294 | calcium gluconate 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337295 | calcium gluceptate 132 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337296 | calcium gluconate 112 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337297 | calcium gluceptate 172 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337298 | calcium gluconate 58.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337299 | calcium gluconate 288 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337300 | calcium gluconate 106 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337301 | cetrimide 400 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337302 | chlormadinone acetate 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337303 | simethicone 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337306 | simethicone 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337310 | simethicone 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337311 | simethicone 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337312 | methylPREDNISolone 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337312 | methylPREDNISolone 20 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 337314 | triamcinolone 0.00105 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337317 | netilmicin 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337318 | netilmicin 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337319 | niacin 640 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337320 | niacin 1000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337321 | niacin 475 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337322 | niacinamide 0.04 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337323 | nicergoline 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337324 | nicergoline 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337325 | nicergoline 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337326 | nicergoline 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337327 | flunarizine 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337328 | flunarizine 8.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337330 | NIFEdipine 33 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337330 | NIFEdipine 33 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 337331 | NIFEdipine 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337331 | NIFEdipine 40 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 337332 | nifuratel 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337333 | nifuratel 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337334 | nifuroxazide 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337335 | nifurzide 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337336 | nifurzide 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337337 | nikethamide 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337338 | nilutamide 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337339 | nimesulide 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337340 | nimesulide 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337341 | nimesulide 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337342 | niMODipine 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337342 | niMODipine 40 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 337343 | niMODipine 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337343 | niMODipine 10 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 337344 | niMODipine 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337344 | niMODipine 60 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 337345 | nisoldipine 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337346 | nitrazepam 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337347 | nitrendipine 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337348 | nitrofurazone 2.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337350 | nitroglycerin 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337352 | nitroglycerin 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337353 | nitroglycerin 6.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337354 | nitroprusside 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337355 | nitroxoline 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337356 | nizatidine 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337357 | nomegestrol 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337358 | norethindrone 0.833 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337359 | mestranol 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337362 | norethynodrel 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337363 | norfenefrine 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337364 | norgestrel 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337365 | noscapine 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337366 | noscapine 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337368 | escin 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337369 | nylidrin 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337371 | obidoxime 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337372 | ofloxacin 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337374 | ondansetron 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337375 | ondansetron 16 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337377 | ornidazole 167 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337378 | ornipressin 5 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 33738 | pioglitazone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 33738 | pioglitazone | Designated preferred name (PT) | YES | |
| RxCUI: 33738 | pioglitazone | Full form of descriptor (FN) | YES | |
| RxCUI: 33738 | pioglitazone | Designated preferred name (PT) | YES | |
| RxCUI: 33738 | pioglitazone | Full form of descriptor (FN) | YES | |
| RxCUI: 337380 | orphenadrine 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337381 | niflumic acid 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337382 | orphenadrine 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337383 | oxaceprol 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337384 | carbocysteine 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337386 | oxatomide 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337387 | oxatomide 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337388 | oxatomide 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337389 | oxeladin 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 33739 | pipamperone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33739 | pipamperone | Designated preferred name (PT) | NO | |
| RxCUI: 33739 | pipamperone | Full form of descriptor (FN) | NO | |
| RxCUI: 33739 | pipamperone | Designated preferred name (PT) | NO | |
| RxCUI: 33739 | pipamperone | Full form of descriptor (FN) | NO | |
| RxCUI: 337390 | oxeladin 17.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337391 | oxeladin 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337392 | oxeladin 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337393 | oxeladin 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337395 | chlorthalidone 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337396 | chlorthalidone 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337397 | oxtriphylline 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337398 | oxtriphylline 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 33740 | Pipazetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 33740 | Pipazetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33740 | Pipazetate | Designated preferred name (PT) | NO | |
| RxCUI: 33740 | Pipazetate | Full form of descriptor (FN) | NO | |
| RxCUI: 337401 | oxypertine 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337402 | oxytetracycline 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337405 | pamidronate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337408 | vitamin B6 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337409 | pancreatin 340 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337410 | pancreatin 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337411 | prednisolone 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337411 | prednisolone 25 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 337412 | simethicone 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337413 | simethicone 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337414 | simethicone 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337418 | vidarabine 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337419 | zinc gluconate 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 33742 | Pipecuronium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33742 | Pipecuronium | Designated preferred name (PT) | NO | |
| RxCUI: 33742 | Pipecuronium | Full form of descriptor (FN) | NO | |
| RxCUI: 33742 | Pipecuronium | Designated preferred name (PT) | NO | |
| RxCUI: 33742 | Pipecuronium | Full form of descriptor (FN) | NO | |
| RxCUI: 337420 | zinc gluconate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337421 | zinc gluconate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337422 | zinc gluconate 23 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337423 | zinc gluconate 13.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337424 | zinc gluconate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337425 | zinc gluconate 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337426 | zinc gluconate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337427 | zinc gluconate 22.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337428 | zinc gluconate 390 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337429 | zinc gluconate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 33743 | pipenzolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33743 | pipenzolate | Designated preferred name (PT) | NO | |
| RxCUI: 33743 | pipenzolate | Full form of descriptor (FN) | NO | |
| RxCUI: 33743 | pipenzolate | Designated preferred name (PT) | NO | |
| RxCUI: 33743 | pipenzolate | Full form of descriptor (FN) | NO | |
| RxCUI: 337430 | zinc gluconate 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337431 | zinc gluconate 78 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337432 | zinc gluconate 6.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337433 | zinc gluconate 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337434 | zinc gluconate 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337435 | zinc gluconate 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337436 | zinc gluconate 33.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337438 | vidarabine 0.03 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337439 | zinc gluconate 22 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337440 | zinc gluconate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337442 | phosphorus 1.04 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337443 | zinc gluconate 77 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337444 | estradiol 0.00417 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337446 | Podophyllum preparation 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337447 | calcium ascorbate 800 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337448 | calcium gluconate 325 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337449 | calcium gluconate 975 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 33745 | Piperaquine | Designated preferred name (PT) | NO | |
| RxCUI: 33745 | Piperaquine | Full form of descriptor (FN) | NO | |
| RxCUI: 337450 | calcium gluconate 700 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337451 | calcium gluconate 23.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337458 | phosphorus 172 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 33746 | Piperazine calcium edetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 33746 | Piperazine calcium edetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 33746 | Piperazine calcium edetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 33746 | Piperazine calcium edetate | Designated preferred name (PT) | NO | |
| RxCUI: 33746 | Piperazine calcium edetate | Full form of descriptor (FN) | NO | |
| RxCUI: 337463 | estradiol 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337464 | ethinyl estradiol 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337465 | zinc gluconate 105 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337466 | zinc gluconate 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337469 | belladonna alkaloids 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 33747 | Piperazine estrone sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 33747 | Piperazine estrone sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 33747 | Piperazine estrone sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 33747 | Piperazine estrone sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 33747 | Piperazine estrone sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 33747 | Piperazine estrone sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 337470 | calcium creosotate 259 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337471 | calcium gluconate 488 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337474 | calcium glubionate 138 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337475 | calcium gluceptate 125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337476 | choline salicylate 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337477 | niacin 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337479 | nicergoline 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337480 | nifuratel 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337481 | nifuratel 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337482 | nifuroxazide 44 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337483 | nimorazole 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337484 | nitrazepam 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337485 | nitrendipine 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337486 | nitrendipine 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337487 | norfenefrine 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337488 | noscapine 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337489 | oxatomide 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337490 | oxytetracycline 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337491 | oxytetracycline 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337492 | pancreatin 1400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337493 | pancreatin 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337494 | pancreatin 350 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337495 | zinc gluconate 11.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337496 | zinc gluconate 44 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337497 | caffeine 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337499 | boron citrate 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337500 | calcium gluconate 486 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337501 | levonorgestrel 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337503 | orphenadrine 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337507 | chondroitin sulfates 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337509 | carmustine 3.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337511 | Eloxatin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 33752 | piperocaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33752 | piperocaine | Designated preferred name (PT) | NO | |
| RxCUI: 33752 | piperocaine | Full form of descriptor (FN) | NO | |
| RxCUI: 337521 | Avastin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 337523 | ixabepilone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 337523 | ixabepilone | Designated preferred name (PT) | YES | |
| RxCUI: 337523 | ixabepilone | Full form of descriptor (FN) | YES | |
| RxCUI: 337523 | ixabepilone | Designated preferred name (PT) | YES | |
| RxCUI: 337523 | ixabepilone | Full form of descriptor (FN) | YES | |
| RxCUI: 337525 | Erlotinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 337525 | Erlotinib | Designated preferred name (PT) | YES | |
| RxCUI: 337525 | Erlotinib | Full form of descriptor (FN) | YES | |
| RxCUI: 337525 | Erlotinib | Designated preferred name (PT) | YES | |
| RxCUI: 337525 | Erlotinib | Full form of descriptor (FN) | YES | |
| RxCUI: 337526 | Tarceva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 33753 | piperonal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 337535 | Revlimid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 337539 | Cortone acetate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 33755 | Piperilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 33755 | Piperilate | Designated preferred name (PT) | NO | |
| RxCUI: 33755 | Piperilate | Full form of descriptor (FN) | NO | |
| RxCUI: 337553 | rofecoxib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337557 | trimethoprim 9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337558 | trimethoprim 90 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337559 | trimethoprim 180 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 337560 | cefTRIAXone 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337560 | cefTRIAXone 100 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 337561 | cefOXitin 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 337561 | cefOXitin 200 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 33758 | pipoxolan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 337592 | NADPH-dependent carbonyl reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337592 | NADPH-dependent carbonyl reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337592 | NADPH-dependent carbonyl reductase | Designated preferred name (PT) | NO | |
| RxCUI: 337592 | NADPH-dependent carbonyl reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337592 | NADPH-dependent carbonyl reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 337592 | NADPH-dependent carbonyl reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337592 | NADPH-dependent carbonyl reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337592 | NADPH-dependent carbonyl reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 33761 | piprozolin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 33761 | piprozolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 337623 | Dornase alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 337623 | Dornase alfa | Designated preferred name (PT) | YES | |
| RxCUI: 337623 | Dornase alfa | Full form of descriptor (FN) | YES | |
| RxCUI: 337623 | Dornase alfa | Designated preferred name (PT) | YES | |
| RxCUI: 337623 | Dornase alfa | Full form of descriptor (FN) | YES | |
| RxCUI: 33764 | Pirarubicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33764 | Pirarubicin | Designated preferred name (PT) | NO | |
| RxCUI: 33764 | Pirarubicin | Full form of descriptor (FN) | NO | |
| RxCUI: 33767 | pirbuterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 33767 | pirbuterol | Designated preferred name (PT) | YES | |
| RxCUI: 33767 | pirbuterol | Full form of descriptor (FN) | YES | |
| RxCUI: 33767 | pirbuterol | Designated preferred name (PT) | YES | |
| RxCUI: 33767 | pirbuterol | Full form of descriptor (FN) | YES | |
| RxCUI: 33770 | piretanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 33770 | piretanide | Designated preferred name (PT) | NO | |
| RxCUI: 33770 | piretanide | Full form of descriptor (FN) | NO | |
| RxCUI: 33770 | piretanide | Designated preferred name (PT) | NO | |
| RxCUI: 33770 | piretanide | Full form of descriptor (FN) | NO | |
| RxCUI: 337786 | Tretoquinol hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 337786 | Tretoquinol hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 33782 | Pirmenol | Designated preferred name (PT) | NO | |
| RxCUI: 33782 | Pirmenol | Full form of descriptor (FN) | NO | |
| RxCUI: 337823 | Mono(ADP-ribosyl)transferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337823 | Mono(ADP-ribosyl)transferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337823 | Mono(ADP-ribosyl)transferase | Designated preferred name (PT) | NO | |
| RxCUI: 337823 | Mono(ADP-ribosyl)transferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337823 | Mono(ADP-ribosyl)transferase | Full form of descriptor (FN) | NO | |
| RxCUI: 33783 | piroctone olamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 337840 | Vaginal Suppository | Dose Form (DF) | NO | |
| RxCUI: 33787 | piroxicam cinnamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 337879 | Complement receptor 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337879 | Complement receptor 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 337879 | Complement receptor 3 | Designated preferred name (PT) | NO | |
| RxCUI: 337879 | Complement receptor 3 | Full form of descriptor (FN) | NO | |
| RxCUI: 337879 | Complement receptor 3 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 337879 | Complement receptor 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 33798 | Vasopressin tannate | Designated preferred name (PT) | NO | |
| RxCUI: 33798 | Vasopressin tannate | Full form of descriptor (FN) | NO |